Join the 200th Anniversary Celebration

Special Article

The Economic Impact of Multiple-Gestation Pregnancies and the Contribution of Assisted-Reproduction Techniques to Their Incidence

Tamara L. Callahan, Janet E. Hall, Susan L. Ettner, Cindy L. Christiansen, Michael F. Greene, and William F. Crowley, Jr.

N Engl J Med 1994; 331:244-249July 28, 1994

Abstract

Background

Although the medical complications associated with multiple-gestation pregnancies have been well documented, little is known about the effects of such pregnancies on the use of health care resources and the associated costs. This is an important issue because of the increasing use of assisted-reproduction techniques, which commonly result in multiple-gestation pregnancies.

Methods

We determined hospital charges and the use of assisted-reproduction techniques (such as induction of ovulation, in vitro fertilization, and gamete intrafallopian transfer) for 13,206 pregnant women (11,986 with singleton pregnancies, 1135 with twin pregnancies, and 85 with more than two fetuses) who were admitted for delivery to Brigham and Women's Hospital, Boston, in 1986 through 1991 and their 14,033 neonates (11,671 singletons, 2144 twins, and 218 resulting from higher-order multiple gestations).

Results

After we controlled for variables known to affect hospital charges, the predicted total charges to the family in 1991 for a singleton delivery were $9,845, as compared with $37,947 for twins ($18,974 per baby) and $109,765 for triplets ($36,588 per baby). Assisted-reproduction techniques were used in 2 percent of singleton, 35 percent of twin, and 77 percent of higher-order multiple-gestation pregnancies; such procedures were approximately equally divided between induction of ovulation alone and in vitro fertilization or gamete intrafallopian transfer.

Conclusions

Multiple-gestation pregnancies, a high proportion of which result from the use of assisted-reproduction techniques, dramatically increase hospital charges. If all the multiple gestations resulting from assisted-reproduction techniques had been singleton pregnancies, the predicted savings to the health care delivery system in the study hospital alone would have been over $3 million per year. Although assisted reproduction provides tremendous benefits to families with infertility, the increased medical risks entailed by multiple-gestation pregnancies and the associated costs cannot be ignored. We suggest that more attention be paid to approaches to infertility that reduce the likelihood of multiple gestation.

Media in This Article

Figure 1Hospital Charges for Singleton, Twin, and Higher-Order Multiple-Gestation Pregnancies.
Figure 2Mean Predicted Maternal and Neonatal Daily Charges and Lengths of Stay, According to Type of Gestation.
Article

In the United States, 8.5 percent of married couples are infertile1. Although the overall incidence of infertility did not increase between 1968 and 1982, the number of visits to physicians for treatment of infertility nearly tripled1. This increase in visits to physicians was due in part to the availability of new treatment methods, including induction of ovulation by the administration of exogenous gonadotropins, in vitro fertilization, gamete intrafallopian transfer, egg and sperm donation, and surrogacy. Since the first baby was born as a result of in vitro fertilization in 1978, more than 14,000 have been born worldwide as a result of this technique alone2.

These treatments for infertility not only have the potential to alleviate infertility but also entail the risk of inducing multiple-gestation pregnancies. It is possible, however, for physicians to control this risk to a substantial extent. The incidence of multiple-gestation pregnancies ranges from 10 to 15 percent with the use of gonadotropins alone; the incidence is at least 15 to 20 percent when gonadotropins are used in combination with intrauterine insemination,3 and it is reported to be 15 to 30 percent with in vitro fertilization2,4-7. These rates must be compared with the spontaneous twinning rate of 1.05 to 1.35 percent in the United States and the rate of 0.01 to 0.017 percent for the conception of triplets8. Several recent national studies of the increasing incidence of multiple-gestation pregnancies indicate that the vast majority of higher-order multiple gestations (63 to 80 percent) are a direct result of the use of assisted reproduction6,9-13.

The accelerating rate of multiple births has been a cause for concern on the part of physicians and medical economists alike. The increased incidence of maternal and neonatal complications associated with multiple-gestation pregnancies has been well documented,9,11,13-16 and the greater likelihood of prematurity alone contributes substantially to neonatal risk10,12,15,17,18. In spite of improvements in the outcome of multiple-gestation pregnancies as a result of advances in care,5,9,11,12,14,17 the perinatal mortality rate in such pregnancies remains 3 to 10 times that in singleton pregnancies8,12,15,16,18-20.

We investigated the economic impact of multiple-gestation pregnancies, controlling for variables known to affect hospital charges, and examined the contribution of assisted reproduction to the incidence of multiple pregnancies and the associated charges.

Methods

Patients

The study was approved by the human research committees of Brigham and Women's Hospital and Massachusetts General Hospital. We examined the computerized medical and billing records of 13,206 pregnant women admitted for delivery at more than 20 weeks' gestation to Brigham and Women's Hospital from 1986 through 1991 and the records of their 14,033 neonates; data were obtained from the mother's admission to the discharge of all family members from the hospital. All multiple-gestation pregnancies were identified and compared with a random sample of approximately 2000 singleton deliveries for each year. Only babies with medical records were included, and all babies who lived less than one day were excluded because of the inconsistency of coding for intrauterine deaths; one mother who died within one day of severe medical complications was also excluded. Analyses were performed on data for 11,986 women with singleton pregnancies, 1135 with twin pregnancies, and 85 with more than two fetuses and on data for 11,671 singleton neonates, 2144 twins, and 218 neonates delivered after higher-order multiple-gestation pregnancies.

The mother's age, race or ethnic group, insurance coverage, type and length of gestation, type of delivery (vaginal or cesarean), and dates of admission and discharge and the neonate's sex, dates of admission and discharge, admission to the intensive care unit, and health status and destination (community hospital, home, or another tertiary center) at discharge were obtained along with inpatient hospital charges for both the mother and the infant. The billing records did not include physicians' charges, charges for outpatient prenatal care, actual costs of assisted-reproduction services, charges for hospitalizations before the admission for delivery, or charges for neonatal care if the infant was transferred to another hospital. Daily charges (total charges divided by the total length of stay) for the mother and infant were calculated as a measure of the intensity of treatment.

To examine the link between the use of assisted-reproduction techniques and the incidence of multiple gestation and to look for trends over time in our study population, we reviewed hospital charts and conducted follow-up telephone surveys for all multiple-gestation pregnancies with more than two fetuses in each year of the study and for a random sample of 100 singleton infants and all twins delivered in 1991. If assisted-reproduction techniques were used, the general type (ovulation-induction agents with or without intrauterine insemination vs. in vitro fertilization or gamete intrafallopian transfer) was noted.

Statistical Analysis

Frequency distributions according to the type of gestation (singleton, twin, or higher-order multiple) were determined for subgroups of the sample defined according to maternal age, race or ethnic group, type of insurance, year of admission, predelivery and post-delivery length of stay, need for cesarean section, duration of pregnancy, and the neonate's sex, admission to the intensive care unit, and status at discharge. Neonatal mortality data were based on neonates coded as deceased at discharge and on comparison of maternal and neonatal records. Reviews of maternal records for all twin and higher-order multiple-gestation pregnancies for which corresponding neonatal information was missing confirmed the occurrence of intrauterine death in every case. Intrauterine death was also assumed to have occurred when the maternal records in singleton pregnancies lacked corresponding information on the neonate. Analysis of variance was used to test for significant differences according to the type of gestation.

Separate ordinary least-squares analyses of the logarithmic transformation of maternal and neonatal total charges, daily charges, and lengths of stay were performed as a function of type of gestation and the control variables. Predicted values for these outcomes were obtained through a retransformation algorithm and correction term in order to estimate the mean of the original distribution, as previously described21. Maternal control variables included in the final analysis were age and the indicator variables for race or ethnic group (black, Hispanic, white, and other), type of insurance (commercial [private, fee-for-service], health maintenance organization [HMO], Medicaid, Medicare, or no insurance), and year of admission (to account for all trends over time, including inflation and trends in medical and insurance practice). Neonatal control variables included sex and the maternal characteristics. The reference value in the analyses of maternal data represents the estimated value of the dependent variable for a 29-year-old white (nonblack, non-Hispanic) woman with commercial insurance admitted for a singleton delivery in 1991. The reference value in the neonatal analyses represents the estimated value for a female neonate whose mother had the characteristics just described.

The percentage of singleton, twin, and higher-order multiple-gestation pregnancies conceived as a result of assisted reproduction in 1991 was analyzed according to type of gestation and method of assisted reproduction. The percentage of higher-order multiple-gestation pregnancies resulting from assisted-reproduction procedures was compared for the years from 1986 to 1991 according to year of admission.

Results

The number of mothers who had twins delivered at Brigham and Women's Hospital increased by an average of 9 percent per year, from 146 in 1986 to 221 in 1991, whereas higher-order multiple-gestation deliveries increased by approximately 19 percent per year, from 8 sets in 1986 to a peak of 23 sets in 1990.

Women with twin and higher-order multiple-gestation pregnancies were older than those with singleton pregnancies, were more likely to be white, and were more likely to have comprehensive health insurance (commercial insurance or HMO coverage) than mothers of singletons (Table 1Table 1Characteristics of Mothers and Newborns According to Type of Gestation.). The sex distribution of the neonates was similar in all three gestational groups.

Maternal Outcomes

After we controlled for the mother's age, race or ethnic group, type of insurance, and year of admission, there was a significant difference in the mean hospital charges among the mothers with singleton, twin, and higher-order multiple-gestation pregnancies (Figure 1Figure 1Hospital Charges for Singleton, Twin, and Higher-Order Multiple-Gestation Pregnancies.). Hospital charges for a 29-year-old white woman with a singleton pregnancy and commercial insurance who was admitted in 1991 (the reference value) were $4,838, as compared with $7,991 for a mother of twins and $15,379 for a mother with a higher-order multiple-gestation pregnancy (P<0.001).

Of the control variables used in the regression analysis (Table 2Table 2The Effect of Maternal and Neonatal Characteristics on Charges and Length of Stay.), an increase in total charges was seen with multiple gestation, maternal age over 29 years, insurance coverage by Medicaid or Medicare, and no insurance coverage. HMO coverage resulted in a decrease in these charges, whereas being black or Hispanic had no statistically significant effect. Charges increased an average of 11.8 percent per year from 1986 to 1991. There was a small difference in daily charges among women with singleton ($1,296), twin ($1,275), and higher-order multiple-gestation pregnancies ($1,174; P<0.001) (Figure 2Figure 2Mean Predicted Maternal and Neonatal Daily Charges and Lengths of Stay, According to Type of Gestation.).

The average stay for the mother of a singleton neonate was 4.0 days, as compared with 6.8 days for the mother of twins and 14.1 days for the mother of higher-order multiple neonates (P<0.001) (Figure 2). Multiple gestation, Medicare coverage, and age over 29 years increased the mother's length of stay, whereas Medicaid and HMO coverage decreased it (Table 2). Being Hispanic decreased the length of stay, whereas being black had no effect on this variable. Maternal lengths of stay decreased each year from 1986 to 1991.

Thus, the difference in total maternal charges can be attributed to the increased length of stay for the mothers of twins and higher-order multiple newborns, rather than to differences in daily charges. There was an increased incidence of cesarean section (24 percent, 59 percent, and 86 percent, for singleton, twin, and higher-order multiple-gestation deliveries, respectively) and delivery at less than 38 weeks (24 percent, 67 percent, and 93 percent, respectively; P<0.001).

Neonatal Outcomes

The total hospital charges for the average baby girl born in 1991 to a white, 29-year-old mother with commercial insurance coverage were $5,007, as compared with $14,978 for each twin neonate and $31,462 for each neonate born after a higher-order multiple-gestation pregnancy (P<0.001) (Figure 1). Although being black had no effect on charges, being Hispanic, maternal age over 29 years, and HMO insurance coverage each resulted in a decrease in total neonatal charges; coverage by Medicaid or Medicare, a lack of insurance coverage, and male sex resulted in an increase (Table 2). Daily charges increased from $591 for a singleton neonate to $996 for each twin, and to $1,715 for each infant born after a higher-order multiple-gestation pregnancy (P<0.001) (Figure 2). Neonatal charges also increased each year from 1986 to 1991.

The average neonatal length of stay increased from 4.6 days for each singleton to 8.2 days for each twin and 10.0 days for each higher-order multiple neonate (P<0.001) (Figure 2 and Table 2). Being black and male and coverage by Medicare increased the length of stay, which was, conversely, decreased by HMO coverage (Table 2). The length of stay was shorter for each successive year from 1986 to 1991.

Fifteen percent of singleton neonates were admitted to the neonatal intensive care unit, as compared with 48 percent of twins and 78 percent of higher-order multiple neonates (P<0.001). A higher percentage of twins and newborns delivered after higher-order multiple-gestation pregnancies were discharged to step-down or community nurseries than of singletons (6 percent of singletons vs. 24 percent of twins and 60 percent of higher-order multiple neonates; P<0.001). Charges for hospitalization after discharge from Brigham and Women's Hospital were not included in the current study. In addition, 2.6 percent of singletons were either stillborn or died before discharge, as compared with 6.0 percent of twins and 13.7 percent of higher-order multiple neonates.

Total Family Charges

Because of the effects of multiple gestation on both maternal and neonatal charges, the most meaningful assessment of charges is obtained by combining the two and considering total family charges (Figure 1). After we controlled for variables that might independently affect hospital charges, the total charge per family in 1991 was $9,845 for a 29-year-old white mother of a single neonate and her child, as compared with $37,947 for a mother of twins and her two children and $109,765 for a mother of triplets and her three children. If these charges are expressed in terms of the number of babies delivered, a twin delivery approximately doubles the maternal and neonatal charges from $9,845 for each baby to $18,974 per baby, whereas delivery of triplets would result in charges of $36,588 per baby.

Use of Assisted-Reproduction Techniques

The use of assisted-reproduction techniques was more frequent among women with twin and higher-order multiple-gestation pregnancies than among those with singleton gestations in 1991 (Figure 3Figure 3Percentage of Pregnancies at the Study Hospital in 1991 Resulting from Assisted-Reproduction Techniques.). Of the random sample of 100 singleton pregnancies in 1991, only 2 percent resulted from documented use of assisted-reproduction techniques. Of the 221 sets of twins delivered in 1991, 65 percent were conceived spontaneously, whereas 35 percent resulted from the use of assisted-reproduction procedures, which were equally divided between induction of ovulation alone and in vitro fertilization or gamete intrafallopian transfer. Only 23 percent of newborns delivered in 1991 after higher-order multiple-gestation pregnancies were conceived spontaneously, whereas 77 percent were conceived with reproductive assistance (ovulation-induction agents in 31 percent and in vitro fertilization or gamete intrafallopian transfer in 46 percent). Review of all higher-order multiple-gestation pregnancies from 1986 to 1991 indicated that a similar proportion resulted from the use of assisted-reproduction techniques in each of the six years of this study (75 to 86 percent per year).

Discussion

Our study indicates that multiple-gestation pregnancies result in substantially increased hospital charges for both mothers and neonates, producing a dramatic increase in total medical costs as compared with the costs of singleton pregnancies. Even if many couples plan to have more than one child, a twin or triplet gestation is clearly disadvantageous from an economic standpoint alone. Our study also addresses the contribution of assisted-reproduction techniques to the incidence of multiple gestation; we found that 77 percent of the triplets and 35 percent of the twins delivered at the study hospital were conceived through the use of such techniques. The contribution of assisted reproduction to gestations of more than two fetuses was similar in each of the years of the study and was almost identical to that reported in a previous study at the same hospital for 1983 through 19876. In 1991, 10 of 13 sets of triplets and 77 of 221 sets of twins were conceived with the help of assisted-reproduction techniques. If each of these multiple pregnancies had been a singleton pregnancy, the savings would have been more than $3 million in this one hospital for one year.

We recognize that there is the possibility of bias in our analysis of charges as opposed to costs. Data on costs were not available, but even if the mix of services differed according to type of gestation, assuming that profit margins for all services are similar, the percent increase in costs due to multiple gestation should be similar to the percent increase in charges22. An important additional feature of this analysis is that the neonatal and maternal charges in our study clearly underestimate overall charges associated with multiple-gestation pregnancies. A substantial percentage of twin and higher-order multiple neonates were transferred to step-down facilities. The additional hospital charges were not captured in the current analysis, nor were the physicians' fees or charges for in-home follow-up or long-term care of patients with disabilities associated with premature delivery and multiple gestation16,20. In addition, the economic impact of the increase in neonatal mortality (6 percent among twins and 13.7 percent among neonates in higher-order multiple-gestation pregnancies in the current series) cannot be quantified. Maternal charges also do not include any physicians' charges (billed separately), charges associated with treatment of infertility, outpatient obstetrical management of high-risk pregnancies, loss of time from work for bed rest, or admissions before the admission for delivery.

It is likely that our analysis also underestimates the effects of multiple gestation on medical costs, since it was not possible to control for maternal health, socioeconomic status, or prenatal care, all of which are inversely related to health care costs and all of which would be expected to be good in patients receiving assisted-reproduction treatment12,13,23,24. Maternal health, socioeconomic status, and prenatal care are also likely to explain the increased charges for mothers with Medicaid and Medicare coverage (in this age group, the Medicare category is likely to include only mothers who are disabled). Conversely, HMOs attract healthier people on average,25 and this selection bias may underlie the lower charges among families with HMO coverage.

Currently, there is substantial economic pressure and pressure from patients for infertility-treatment programs to increase their success rates. Among the strategies used are increasing the number of ovarian follicles matured by the administration of exogenous gonadotropin during induction of ovulation and increasing the number of embryos or gametes transferred in cases of in vitro fertilization or gamete intrafallopian transfer. Each of these strategies is aimed at increasing the percentage of successful pregnancies but also substantially increases the likelihood of multiple gestations. That increase, in turn, drives obstetrical and neonatal charges higher. Many fear that decreasing the number of follicles stimulated or the number of embryos transferred in order to reduce the number of multiple gestations will lead to lower success rates and an increase in the number of menstrual cycles of treatment needed to achieve a pregnancy. However, the cost for these additional cycles, though they are by no means inexpensive, may well be a tolerable trade-off for lowering the medical and economic costs of multiple-gestation pregnancies.

A number of strategies are also being used to improve the outcomes of multiple-gestation pregnancies, which commonly result in an increased incidence of prematurity. Selective fetal reduction has been used to achieve this end,26,27 but it presents an ethical problem for many couples, entails the risk of losing all fetuses being carried,26-28 and increases psychological stress for couples who have struggled through years of infertility. Other strategies that have focused on the prevention of premature delivery through intensive antenatal monitoring and interventions have been only partially successful in controlling the complications of multiple-gestation pregnancies29-31. Neonatal intensive care units have been responsible for substantial improvements in the outcome of multiple-gestation pregnancies, but again with the obvious drawback of dramatically increased charges32-34.

Each of these proposed methods of improving the outcome of multiple-gestation pregnancies relies on post hoc measures used after multiple gestation has been established. A preferable and more economical solution would be to avoid the conception of multiple fetuses. Several studies have shown that the number of multiple-gestation pregnancies can be decreased by the more judicious use of ovulation-induction agents and by increased monitoring,15,35-37 by reducing the number of embryos transferred in cases of in vitro fertilization and gamete intrafallopian transfer,4,38-40 and by the use of less common but safer agents to induce ovulation, such as pulsatile gonadotropin-releasing hormone3.

Now that the risks, causes, and economic impact of multiple-gestation pregnancies have been identified and the women most likely to have such pregnancies have been characterized, physicians have a unique opportunity to institute strategies to reduce the number of multiple-gestation pregnancies. Such strategies necessitate the acknowledgment of the risks in twin gestations as well as higher-order multiple-gestation pregnancies, since the goal of these innovative techniques is to maximize the probability of a singleton pregnancy and the birth of a healthy infant to infertile couples while minimizing the morbidity, mortality, and expense associated with multiple-gestation pregnancies.

Supported by a grant (U54-HD-29164) from the National Institutes of Health.

We are indebted to Katrina Pease for her invaluable assistance in setting up the data base, to the General Clinical Research Center at Massachusetts General Hospital (under grant MO1-RR-01066), to Sharon Best for advice on data-base management, and to Michael McClure, Ph.D., at the National Institute on Child Health and Human Development for his support of these activities.

Source Information

From the National Center for Infertility Research at Massachusetts General Hospital as part of the National Cooperative Program on Infertility Research of the National Institute on Child Health and Human Development and the Department of Medicine, Massachusetts General Hospital (T.L.C., J.E.H., W.F.C.); Harvard Medical School (T.L.C.); the Department of Health Care Policy, Harvard Medical School (S.L.E., C.L.C.); and the Department of Obstetrics-Gynecology, Brigham and Women's Hospital (M.F.G.) -- all in Boston.

Address reprint requests to Dr. Hall at the Reproductive Endocrine Unit, Massachusetts General Hospital, Bartlett Hall Extension 5, Fruit St., Boston, MA 02114.

References

References

  1. 1

    Infertility: medical and social choices. Washington, D.C.: Congress of the United States, Office of Technology Assessment, 1988.

  2. 2

    Assisted reproductive technology in the United States and Canada: 1991 results from the Society for Assisted Reproductive Technology generated from the American Fertility Registry. Fertil Steril 1993;59:956-962
    Web of Science | Medline

  3. 3

    Martin KA, Hall JE, Adams JM, Crowley WF Jr. Comparison of exogenous gonadotropins and pulsatile gonadotropin-releasing hormone for induction of ovulation in hypogonadotropic amenorrhea. J Clin Endocrinol Metab 1993;77:125-129
    CrossRef | Web of Science | Medline

  4. 4

    Bollen N, Camus M, Staessen C, Tournaye H, Devroey P, Van Steirteghem AC. The incidence of multiple pregnancy after in vitro fertilization and embryo transfer, gamete, or zygote intrafallopian transfer. Fertil Steril 1991;55:314-318
    Web of Science | Medline

  5. 5

    MC Working Party on Children Conceived by In Vitro FertilisationBirths in Great Britain resulting from assisted conception, 1978-87. BMJ 1990;300:1229-1233
    CrossRef | Web of Science

  6. 6

    Rein MS, Barbieri RL, Greene MF. The causes of high-order multiple gestation. Int J Fertil 1990;35:154-156
    Medline

  7. 7

    Schenker JG, Yarkoni S, Granat M. Multiple pregnancies following induction of ovulation. Fertil Steril 1981;35:105-123
    Web of Science | Medline

  8. 8

    Guttmacher AF. The incidence of multiple births in man and some of the other unipara. Obstet Gynecol 1953;2:22-35
    Web of Science | Medline

  9. 9

    Botting BJ, Davies IM, Macfarlane AJ. Recent trends in the incidence of multiple births and associated mortality. Arch Dis Child 1987;62:941-950
    CrossRef | Web of Science | Medline

  10. 10

    Elster AD, Bleyl JL, Craven TE. Birth weight standards for triplets under modern obstetric care in the United States, 1984-1989. Obstet Gynecol 1991;77:387-393
    Web of Science | Medline

  11. 11

    Grutzner-Konnecke H, Grutzner P, Grutzner B, Grutzner U, Spalding-Grutzner A, Spalding P. Higher order multiple births: natural wonder or failure of therapy? Acta Genet Med Gemellol (Roma) 1990;39:491-495
    Web of Science | Medline

  12. 12

    Kiely JL, Kleinman JC, Kiely M. Triplets and higher-order multiple births: time trends and infant mortality. Am J Dis Child 1992;146:862-868
    Web of Science | Medline

  13. 13

    Levene MI, Wild J, Steer P. Higher multiple births and the modern management of infertility in Britain. Br J Obstet Gynaecol 1992;99:607-613
    CrossRef | Medline

  14. 14

    De Muylder X, Moutquin J-M, Desgranges MF, Leduc B, Lazaro-Lopez F. Obstetrical profile of twin pregnancies: a retrospective review of 11 years (1969-1979) at Hopital Notre-Dame, Montreal, Canada. Acta Genet Med Gemellol (Roma) 1982;31:149-155
    Web of Science | Medline

  15. 15

    Lipitz S, Reichman B, Paret G, et al. The improving outcome of triplet pregnancies. Am J Obstet Gynecol 1989;161:1279-1284
    Web of Science | Medline

  16. 16

    Lipitz S, Frenkel Y, Watts C, Ben-Rafael Z, Barkai G, Reichman B. High-order multifetal gestation -- management and outcome. Obstet Gynecol 1990;76:215-218
    Web of Science | Medline

  17. 17

    McCarthy BJ, Sachs BP, Layde PM, Burton A, Terry JS, Rochat R. The epidemiology of neonatal death in twins. Am J Obstet Gynecol 1981;141:252-256
    Web of Science | Medline

  18. 18

    Newman RB, Hamer C, Miller MC. Outpatient triplet management: a contemporary review. Am J Obstet Gynecol 1989;161:547-555
    Web of Science | Medline

  19. 19

    Malmstrom PM, Biale R. An agenda for meeting the special needs of multiple birth families. Acta Genet Med Gemellol (Roma) 1990;39:507-514
    Web of Science | Medline

  20. 20

    Luke B, Keith LG. The contribution of singletons, twins and triplets to low birth weight, infant mortality and handicap in the United States. J Reprod Med 1992;37:661-666
    Web of Science | Medline

  21. 21

    Duan N. Smearing estimate: a nonparametric retransformation method. J Am Stat Assoc 1983;78:605-610
    CrossRef | Web of Science

  22. 22

    Harris J. Pricing rules for hospitals. Bell J Econ 1979;1:224-243
    CrossRef | Web of Science

  23. 23

    Gennaro S, Klein A, Miranda L. Health policy dilemmas related to high technology infertility services. Image J Nurs Sch 1992;24:191-194
    CrossRef | Medline

  24. 24

    Ketterlinus RD, Henderson SH, Lamb ME. Maternal age, sociodemographics, prenatal health and behavior: influences on neonatal risk status. J Adolesc Health Care 1990;11:423-431
    CrossRef | Medline

  25. 25

    Jackson-Beeck M, Kleinman JH. Evidence for self-selection among health maintenance organization enrollees. JAMA 1983;250:2826-2829
    CrossRef | Web of Science | Medline

  26. 26

    Wapner RJ, Davis GH, Johnson A, et al. Selective reduction of multifetal pregnancies. Lancet 1990;335:90-93
    CrossRef | Web of Science | Medline

  27. 27

    Berkowitz RL, Lynch L, Lapinski R, Bergh P. First-trimester transabdominal multifetal pregnancy reduction: a report of two hundred completed cases. Am J Obstet Gynecol 1993;169:17-21
    Web of Science | Medline

  28. 28

    Howie PW. Selective reduction in multiple pregnancy: legal confusion and ethical dilemmas. BMJ 1988;297:433-434
    CrossRef | Web of Science | Medline

  29. 29

    Gilstrap LC III, Brown CE. Prevention and treatment of preterm labor in twins. Clin Perinatol 1988;15:71-77
    Web of Science | Medline

  30. 30

    MacLennan AH, Green RC, O'Shea R, Brookes C, Morris D. Routine hospital admission in twin pregnancy between 26 and 30 weeks' gestation. Lancet 1990;335:267-269
    CrossRef | Web of Science | Medline

  31. 31

    Weekes AR, Menzies DN, de Boer CH. The relative efficacy of bed rest, cervical suture, and no treatment in the management of twin pregnancy. Br J Obstet Gynaecol 1977;84:161-164
    CrossRef | Medline

  32. 32

    Berki SE, Schneier NB. Frequency and cost of diagnosis-related group outliers among newborns. Pediatrics 1987;79:874-881
    Web of Science | Medline

  33. 33

    Ewald U. What is the actual cost of neonatal intensive care? Int J Technol Assess Health Care 1991;7:Suppl 1:155-161
    CrossRef | Medline

  34. 34

    Resnick MB, Ariet M, Carter RL, et al. Prospective pricing system for tertiary neonatal intensive care. Pediatrics 1986;78:820-828
    Web of Science | Medline

  35. 35

    Corson SL, Dickey RP, Gocial B, et al. Outcome in 242 in vitro fertilization-embryo replacement or gamete intrafallopian transfer-induced pregnancies. Fertil Steril 1989;51:644-650
    Web of Science | Medline

  36. 36

    Fauser BCJM, Donderwinkel P, Schoot DC. The step-down principle in gonadotropin treatment and the role of GnRH analogues. Baillieres Clin Obstet Gynaecol 1993;7:309-330
    CrossRef | Web of Science | Medline

  37. 37

    Polson DW, Mason HD, Saldahna MB, Franks S. Ovulation of a single dominant follicle during treatment with low-dose pulsatile follicle stimulating hormone in women with polycystic ovarian syndrome. Clin Endocrinol (Oxf) 1987;26:205-212
    CrossRef | Web of Science | Medline

  38. 38

    Leroy F, Puissant F, Barlow P, de Maertelaer G. Guidelines for the prevention of multiple pregnancy in treatment by in vitro fertilization. Acta Genet Med Gemellol (Roma) 1990;39:371-378
    Web of Science | Medline

  39. 39

    Nijs M, Geerts L, van Roosendaal E, Segal-Bertin G, Vanderzwalmen P, Schoysman R. Prevention of multiple pregnancies in an in vitro fertilization program. Fertil Steril 1993;59:1245-1250
    Web of Science | Medline

  40. 40

    Hecht BR. Iatrogenic multifetal pregnancy. Assist Reprod Rev 1993;3:75-87

Citing Articles (137)

Citing Articles

  1. 1

    Michael P. Diamond, Mohamed Mitwally, Robert Casper, Joel Ager, Richard S. Legro, Robert Brzyski, Peter Casson, Esther Eisenberg, Heping Zhang. (2011) Estimating rates of multiple gestation pregnancies: Sample size calculation from the assessment of multiple intrauterine gestations from ovarian stimulation (AMIGOS) trial. Contemporary Clinical Trials 32:6, 902-908
    CrossRef

  2. 2

    Elizabeth Eisenhauer, David E. Uddin, Pam Albers, Sara Paton, Robert L. Stoughton. (2011) Establishment of a Low Birth Weight Registry and Initial Outcomes. Maternal and Child Health Journal 15:7, 921-930
    CrossRef

  3. 3

    Patricia Katz, Jonathan Showstack, James F. Smith, Robert D. Nachtigall, Susan G. Millstein, Holly Wing, Michael L. Eisenberg, Lauri A. Pasch, Mary S. Croughan, Nancy Adler. (2011) Costs of infertility treatment: results from an 18-month prospective cohort study. Fertility and Sterility 95:3, 915-921
    CrossRef

  4. 4

    Richard H. Reindollar, Meredith M. Regan, Peter J. Neumann, Bat-Sheva Levine, Kim L. Thornton, Michael M. Alper, Marlene B. Goldman. (2010) A randomized clinical trial to evaluate optimal treatment for unexplained infertility: the fast track and standard treatment (FASTT) trial. Fertility and Sterility 94:3, 888-899
    CrossRef

  5. 5

    Lynn B. Davis, Sara J. Champion, Steve O. Fair, Valerie L. Baker, Alan M. Garber. (2010) A cost-benefit analysis of preimplantation genetic diagnosis for carrier couples of cystic fibrosis. Fertility and Sterility 93:6, 1793-1804
    CrossRef

  6. 6

    Elizabeth Barbieri, Sonya Kashyap, Pak H. Chung. 2010. Infertility and In Vitro Fertilization. , 381-399.
    CrossRef

  7. 7

    Robert J. Stillman, Kevin S. Richter, Nicole K. Banks, James R. Graham. (2009) Elective single embryo transfer: A 6-year progressive implementation of 784 single blastocyst transfers and the influence of payment method on patient choice. Fertility and Sterility 92:6, 1895-1906
    CrossRef

  8. 8

    Sharon E. Moayeri, Henry C. Lee, Ruth B. Lathi, Lynn M. Westphal, Amin A. Milki, Alan M. Garber. (2009) Laparoscopy in women with unexplained infertility: a cost-effectiveness analysis. Fertility and Sterility 92:2, 471-480
    CrossRef

  9. 9

    Zsolt Peter Nagy. (2009) Metabolomic testing as a method of predicting IVF success. Expert Review of Obstetrics & Gynecology 4:4, 351-353
    CrossRef

  10. 10

    Monica Kapoor, Lubna Pal. (2009) Epidemic of plurality and contributions of assisted reproductive technology therein. American Journal of Medical Genetics Part C: Seminars in Medical Genetics 151C:2, 128-135
    CrossRef

  11. 11

    Zabeena Pandian, Siladitya Bhattacharya, Ozkan Ozturk, Gamal Serour, Allan Templeton, Zabeena Pandian. 2009. Number of embryos for transfer following in-vitro fertilisation or intra-cytoplasmic sperm injection. .
    CrossRef

  12. 12

    J.S. Krüssel, A.P. Hess, P. Bielfeld. (2008) Häufigkeit und Entwicklungsformen von Mehrlingsschwangerschaften. Der Gynäkologe 41:10, 763-771
    CrossRef

  13. 13

    E Kalu, M-Y Thum, H Abdalla. (2008) Reducing multiple pregnancy in assisted reproduction technology: towards a policy of single blastocyst transfer in younger women. BJOG: An International Journal of Obstetrics & Gynaecology 115:9, 1143-1150
    CrossRef

  14. 14

    Norbert Gleicher, David H Barad. (2008) Arguments against elective single-embryo transfer. Expert Review of Obstetrics & Gynecology 3:4, 481-486
    CrossRef

  15. 15

    B CARVALHO, A SAXENA, A BUTWICK, A MACARIO. (2008) Vaginal twin delivery: a survey and review of location, anesthesia coverage and interventions. International Journal of Obstetric Anesthesia 17:3, 212-216
    CrossRef

  16. 16

    R. Lee, P.S. Li, M. Goldstein, C. Tanrikut, G. Schattman, P.N. Schlegel. (2008) A decision analysis of treatments for obstructive azoospermia. Human Reproduction 23:9, 2043-2049
    CrossRef

  17. 17

    Aaron K. Styer, Diane L. Wright, Anne M. Wolkovich, Christine Veiga, Thomas L. Toth. (2008) Single-blastocyst transfer decreases twin gestation without affecting pregnancy outcome. Fertility and Sterility 89:6, 1702-1708
    CrossRef

  18. 18

    Richard Lee, Philip S. Li, Peter N. Schlegel, Marc Goldstein. (2008) Reassessing Reconstruction in the Management of Obstructive Azoospermia: Reconstruction or Sperm Acquisition?. Urologic Clinics of North America 35:2, 289-301
    CrossRef

  19. 19

    Michael Brandle, William H. Herman. 2008. Cost analysis of diabetes and pregnancy. , 392-398.
    CrossRef

  20. 20

    Elizabeth Doherty. 2008. Multiple Gestation. , 251-254.
    CrossRef

  21. 21

    Gary Stanziano, Niki Istwan. (2008) Cost Analysis of a Maternity Disease Management Program. Disease Management & Health Outcomes 16:2, 107-112
    CrossRef

  22. 22

    Mohamed Khaled Moustafa, Sheded Ashour Sheded, Mohamed Abd El Aziz Mousta. (2008) Elective single embryo transfer versus double embryo transfer in assisted reproduction. Reproductive BioMedicine Online 17:1, 82-87
    CrossRef

  23. 23

    W. Urdl, R. Felberbaum, W. Küpker. (2007) Problem der Mehrlingsschwangerschaft nach assistierter Reproduktion. Gynäkologische Endokrinologie 5:4, 212-218
    CrossRef

  24. 24

    Timothy M. Crombleholme, David Shera, Hanmin Lee, Mark Johnson, Mary D’Alton, Flint Porter, Jacquelyn Chyu, Richard Silver, Alfred Abuhamad, George Saade, Laurence Shields, David Kauffman, Joanne Stone, Craig T. Albanese, Ray Bahado-Singh, Robert H. Ball, Larissa Bilaniuk, Beverly Coleman, Diana Farmer, Vickie Feldstein, Michael R. Harrison, Holly Hedrick, Jeffrey Livingston, Robert P. Lorenz, David A. Miller, Mary E. Norton, William J. Polzin, Julian N. Robinson, Jack Rychik, Per L. Sandberg, Istvan Seri, Erin Simon, Lynn L. Simpson, Larisa Yedigarova, R. Douglas Wilson, Bruce Young. (2007) A prospective, randomized, multicenter trial of amnioreduction vs selective fetoscopic laser photocoagulation for the treatment of severe twin-twin transfusion syndrome. American Journal of Obstetrics and Gynecology 197:4, 396.e1-396.e9
    CrossRef

  25. 25

    James A. Grifo, Eric Flisser, Alexis Adler, Caroline McCaffrey, Lewis C. Krey, Frederick Licciardi, Nicole Noyes, Lisa M. Kump, Alan S. Berkeley. (2007) Programmatic implementation of blastocyst transfer in a university-based in vitro fertilization clinic: maximizing pregnancy rates and minimizing triplet rates. Fertility and Sterility 88:2, 294-300
    CrossRef

  26. 26

    M.F.G. Verberg, N.S. Macklon, E.M.E.W. Heijnen, B.C.J.M. Fauser. (2007) ART: iatrogenic multiple pregnancy?. Best Practice & Research Clinical Obstetrics & Gynaecology 21:1, 129-143
    CrossRef

  27. 27

    Van Voorhis, Bradley J., . (2007) In Vitro Fertilization. New England Journal of Medicine 356:4, 379-386
    Full Text

  28. 28

    John Collins. (2007) Global epidemiology of multiple birth. Reproductive BioMedicine Online 15, 45-52
    CrossRef

  29. 29

    D Bertarelli Späth. (2007) The problem of multiple pregnancies. Reproductive BioMedicine Online 14:2, 242-245
    CrossRef

  30. 30

    François Bissonnette, Jean Cohen, John Collins, Lisa Cowan, Sherry Dale, Sandra Dill, Calvin Greene, Mathias Gysler, Beverly Hanck, Edward Hughes, Arthur Leader, Sarah McDonald, Michael Marrin, Renée Martin, Jason Min, David Mortimer, Sharon Mortimer, Jocelyn Smith, Benjamin Tsang, Dean van Vugt, Albert Yuzpe. (2007) Incidence and complications of multiple gestation in Canada: proceedings of an expert meeting. Reproductive BioMedicine Online 14:6, 773-790
    CrossRef

  31. 31

    Jacques de Mouzon. (2007) The particular problems of ambulatory-controlled ovarian stimulation. Reproductive BioMedicine Online 15, 8-12
    CrossRef

  32. 32

    John Collins. (2007) Cost efficiency of reducing multiple births. Reproductive BioMedicine Online 15, 35-39
    CrossRef

  33. 33

    Sarah E. Little, Jennifer Ratcliffe, Aaron B. Caughey. (2006) Cost of Transferring One Through Five Embryos Per In Vitro Fertilization Cycle From Various Payor Perspectives. Obstetrics & Gynecology 108:3, Part 1, 593-601
    CrossRef

  34. 34

    Mohamed FM Mitwally, Robert F Casper. (2006) Letrozole for ovulation induction. Expert Review of Obstetrics & Gynecology 1:1, 15-27
    CrossRef

  35. 35

    Sushma Sinha. (2006) Newer Concepts in Diagnosis and Management of Infertility. Apollo Medicine 3:1, 75-84
    CrossRef

  36. 36

    Tarek El-Toukhy, Yacoub Khalaf, Peter Braude. (2006) IVF results: Optimize not maximize. American Journal of Obstetrics and Gynecology 194:2, 322-331
    CrossRef

  37. 37

    A Ito, Y Honma, E Inamori, Y Yada, M Y Momoi, Y Nakamura. (2006) Developmental outcome of very low birth weight twins conceived by assisted reproduction techniques. Journal of Perinatology 26:2, 130-133
    CrossRef

  38. 38

    James Bernasko, Robert Lee, Michelle Pagano, Nina Kohn. (2006) Is routine prophylactic cervical cerclage associated with significant prolongation of triplet gestation?. Journal of Maternal-Fetal and Neonatal Medicine 19:9, 575-578
    CrossRef

  39. 39

    Bradley J. Van Voorhis. (2006) Outcomes From Assisted Reproductive Technology. Obstetrics & Gynecology 107:1, 183-200
    CrossRef

  40. 40

    Sirpa Vilska. (2005) Prevention of multiple pregnancies in assisted reproduction. European Clinics in Obstetrics and Gynaecology 1:3, 177-183
    CrossRef

  41. 41

    Gary S. Nakhuda, Mark V. Sauer. (2005) Addressing the Growing Problem of Multiple Gestations Created by Assisted Reproductive Therapies. Seminars in Perinatology 29:5, 355-362
    CrossRef

  42. 42

    Suleena Kansal-Kalra, Magdy P. Milad, William A. Grobman. (2005) In vitro fertilization (IVF) versus gonadotropins followed by IVF as treatment for primary infertility: a cost-based decision analysis. Fertility and Sterility 84:3, 600-604
    CrossRef

  43. 43

    Amy J. Meath, Patrick S. Ramsey, Tammy A. Mulholland, Robert G. Rosenquist, Timothy Lesnick, Kirk D. Ramin. (2005) Comparative longitudinal study of cervical length and induced shortening changes among singleton, twin, and triplet pregnancies. American Journal of Obstetrics and Gynecology 192:5, 1410-1415
    CrossRef

  44. 44

    A. N. Schüring, L. Kiesel. (2005) Hormonelle Therapie des polyzystischen Ovarsyndroms (PLOS). Der Gynäkologe 38:4, 333-341
    CrossRef

  45. 45

    Talha Al-Shawaf, Ariel Zosmer, Martha Dirnfeld, Gedis Grudzinskas. (2005) Safety of Drugs Used in Assisted Reproduction Techniques. Drug Safety 28:6, 513-528
    CrossRef

  46. 46

    MARC GERMOND, MARIE-PIERRE PRIMI, FRANÇOISE URNER, ALAIN CHANSON, DANIEL WIRTHNER, ALFRED SENN. (2004) Number of Transferred Embryos: How to Reduce Multiple Pregnancies. Annals of the New York Academy of Sciences 1034:1, 93-100
    CrossRef

  47. 47

    Theocharis C. Papageorgiou, Juliette Guibert, Michèle Savale, François Goffinet, Charles Fournier, Françoise Merlet, Yvette Janssens, Jean-René Zorn. (2004) Low dose recombinant FSH treatment may reduce multiple gestations caused by controlled ovarian hyperstimulation and intrauterine insemination. BJOG: An International Journal of Obstetrics & Gynaecology 111:11, 1277-1282
    CrossRef

  48. 48

    Zabeena Pandian, Siladitya Bhattacharya, Ozkan Ozturk, Gamal Serour, Allan Templeton, Zabeena Pandian. 2004. Number of embryos for transfer following in-vitro fertilisation or intra-cytoplasmic sperm injection. .
    CrossRef

  49. 49

    (2004) Report on management of obstructive azoospermia. Fertility and Sterility 82, 137-141
    CrossRef

  50. 50

    (2004) Multiple pregnancy associated with infertility therapy. Fertility and Sterility 82, 153-157
    CrossRef

  51. 51

    Takashi Motohashi, Tetsuro Honda, Masaaki Hasegawa, Takafumi Uchida, Naokazu Kanamoto, Koji Koizumi, Michiko Beppu, Takashi Nakahori, Akira Takahashi. (2004) Costs of maternal and neonatal medical care for triplet and quadruplet pregnancies in Japan. Reproductive Medicine and Biology 3:3, 159-164
    CrossRef

  52. 52

    John C. Smulian, Cande V. Ananth, Wendy L. Kinzler, Eftichia Kontopoulos, Anthony M. Vintzileos. (2004) Twin Deliveries in the United States Over Three Decades: An Age-Period-Cohort Analysis. Obstetrics & Gynecology 104:2, 278-285
    CrossRef

  53. 53

    David Frankfurter, James Trimarchi, Rick Hackett, Li Meng, David Keefe. (2004) Monozygotic pregnancies from transfers of zona-free blastocysts. Fertility and Sterility 82:2, 483-485
    CrossRef

  54. 54

    Marianna R. DARE, Caroline A. CROWTHER, Jodie M. DODD, Robert J. NORMAN. (2004) Single or multiple embryo transfer following in vitro fertilisation for improved neonatal outcome: A systematic review of the literature. The Australian and New Zealand Journal of Obstetrics and Gynaecology 44:4, 283-291
    CrossRef

  55. 55

    A RAO, S SAIRAM, H SHEHATA. (2004) Obstetric complications of twin pregnancies. Best Practice & Research Clinical Obstetrics & Gynaecology 18:4, 557-576
    CrossRef

  56. 56

    D CAMPBELL, E VANTEIJLINGEN, L YIP. (2004) Economic and social implications of multiple birth. Best Practice & Research Clinical Obstetrics & Gynaecology 18:4, 657-668
    CrossRef

  57. 57

    C.Matthew Peterson, James C Reading, Harry H Hatasaka, Kirtly Parker Jones, Laurence C Udoff, Eli Y Adashi, Paul H Kuneck, Lisa D Erickson, John W Malo, Bruce F Campbell, Douglas T Carrell. (2004) Use of outcomes-based data in reducing high-order multiple pregnancies: the role of age, diagnosis, and embryo score. Fertility and Sterility 81:6, 1534-1541
    CrossRef

  58. 58

    H.G.Marieke Lukassen, Yvonne Schönbeck, Eddy M.M Adang, Didi D.M Braat, Gerhard A Zielhuis, Jan A.M Kremer. (2004) Cost analysis of singleton versus twin pregnancies after in vitro fertilization. Fertility and Sterility 81:5, 1240-1246
    CrossRef

  59. 59

    Jain, Tarun, Missmer, Stacey A., Hornstein, Mark D., . (2004) Trends in Embryo-Transfer Practice and in Outcomes of the Use of Assisted Reproductive Technology in the United States. New England Journal of Medicine 350:16, 1639-1645
    Full Text

  60. 60

    Michael F. Costello, Sandra Emerson, Therese Miranda, Mo Bashir Bakhtyari, Sarah Clements, Graeme Hughes, Stephen Steigrad. (2004) Case series of a single centre's treatment of ovulatory infertility with clomiphene citrate and intrauterine insemination in 2002. The Australian and New Zealand Journal of Obstetrics and Gynaecology 44:2, 156-159
    CrossRef

  61. 61

    Eli Y. Adashi, Melinda Nebeker Ekins, Yvette LaCoursiere. (2004) On the discharge of Hippocratic obligations: Challenges and opportunities. American Journal of Obstetrics and Gynecology 190:4, 885-893
    CrossRef

  62. 62

    Ginny L Ryan, Sunny H Zhang, Anuja Dokras, Craig H Syrop, Bradley J Van Voorhis. (2004) The desire of infertile patients for multiple births. Fertility and Sterility 81:3, 500-504
    CrossRef

  63. 63

    David Adamson, Valerie Baker. (2004) Multiple births from assisted reproductive technologies: a challenge that must be met. Fertility and Sterility 81:3, 517-522
    CrossRef

  64. 64

    CL Roberts, CS Algert, B Peat, DJ Henderson-Smart. (2004) Trends in place of birth for preterm infants in New South Wales, 1992-2001. Journal of Paediatrics and Child Health 40:3, 139-143
    CrossRef

  65. 65

    EV Kontopoulos, CV Ananth, JC Smulian, AM Vintzileos. (2004) The impact of route of delivery and presentation on twin neonatal and infant mortality: a population-based study in the USA, 1995–97. Journal of Maternal-Fetal and Neonatal Medicine 15:4, 219-224
    CrossRef

  66. 66

    Timur Gurgan, Aygul Demirol. (2004) Why and how should multiple pregnancies be prevented in assisted reproduction treatment programmes?. Reproductive BioMedicine Online 9:2, 237-244
    CrossRef

  67. 67

    Si-Jia Li, Nancy Ford, Karen Meister, Joann Bodurtha. (2003) Increased risk of birth defects among children from multiple births. Birth Defects Research Part A: Clinical and Molecular Teratology 67:10, 879-885
    CrossRef

  68. 68

    Patricia Bolton, Yoshiki Yamashita, Cynthia M Farquhar. (2003) Role of fertility treatments in multiple pregnancy at National Women's Hospital from 1996 to 2001. The Australian and New Zealand Journal of Obstetrics and Gynaecology 43:5, 364-368
    CrossRef

  69. 69

    Marcia A Ellison, Janet E Hall. (2003) Social stigma and compounded losses: quality-of-life issues for multiple-birth families. Fertility and Sterility 80:2, 405-414
    CrossRef

  70. 70

    David Frankfurter. (2003) To insure or not to insure: that is the question. Fertility and Sterility 80:1, 24-26
    CrossRef

  71. 71

    Carson Strong. (2003) Too Many Twins, Triplets, Quadruplets, and So On: A Call for New Priorities. The Journal of Law, Medicine & Ethics 31:2, 272-282
    CrossRef

  72. 72

    Eli Y Adashi, Pedro N Barri, Richard Berkowitz, Peter Braude, Elizabeth Bryan, Judith Carr, Jean Cohen, John Collins, Paul Devroey, René Frydman, David Gardner, Marc Germond, Jan Gerris, Luca Gianaroli, Lars Hamberger, Colin Howles, Howard Jones, Bruno Lunenfeld, Andrew Pope, Meredith Reynolds, Zev Rosenwaks, Laura A Schieve, Gamal I Serour, Françoise Shenfield, Allan Templeton, André Van Steirteghem, Lucinda Veeck, Ulla-Britt Wennerholm. (2003) Infertility therapy-associated multiple pregnancies (births): an ongoing epidemic. Reproductive BioMedicine Online 7:5, 515-542
    CrossRef

  73. 73

    P De Sutter, J Van der Elst, T Coetsier, M Dhont. (2003) Single embryo transfer and multiple pregnancy rate reduction in IVF/ICSI: a 5-year appraisal. Reproductive BioMedicine Online 6:4, 464-469
    CrossRef

  74. 74

    Siladitya Bhattacharya. (2003) Effective use of assisted reproduction. Human Fertility 6:2s, S60-S62
    CrossRef

  75. 75

    Peter R Brinsden. (2003) Controlling the high order multiple birth rate: the European perspective. Reproductive BioMedicine Online 6:3, 339-344
    CrossRef

  76. 76

    John L Frattarelli, Mark P Leondires, Jeffrey L McKeeby, Bradley T Miller, James H Segars. (2003) Blastocyst transfer decreases multiple pregnancy rates in in vitro fertilization cycles: a randomized controlled trial. Fertility and Sterility 79:1, 228-230
    CrossRef

  77. 77

    Peter N Kolettis, Edmund S Sabanegh, Anna M D’amico, Lyndon Box, Michael Sebesta, John R Burns. (2002) Outcomes for vasectomy reversal performed after obstructive intervals of at least 10 years. Urology 60:5, 885-888
    CrossRef

  78. 78

    Jain, Tarun, Harlow, Bernard L., Hornstein, Mark D., . (2002) Insurance Coverage and Outcomes of in Vitro Fertilization. New England Journal of Medicine 347:9, 661-666
    Full Text

  79. 79

    B. Blondel, M. D. Kogan, G. R. Alexander, N. Dattani, M. S. Kramer, A. Macfarlane, S. W. Wen. (2002) The Impact of the Increasing Number of Multiple Births on the Rates of Preterm Birth and Low Birthweight: An International Study. American Journal of Public Health 92:8, 1323-1330
    CrossRef

  80. 80

    Ira D Sharlip, Jonathan P Jarow, Arnold M Belker, Larry I Lipshultz, Mark Sigman, Anthony J Thomas, Peter N Schlegel, Stuart S Howards, Ajay Nehra, Marian D Damewood, James W Overstreet, Richard Sadovsky. (2002) Best practice policies for male infertility. Fertility and Sterility 77:5, 873-882
    CrossRef

  81. 81

    JONATHAN P. JAROW, IRA D. SHARLIP, ARNOLD M. BELKER, LARRY I. LIPSHULTZ, MARK SIGMAN, ANTHONY J. THOMAS, PETER N. SCHLEGEL, STUART S. HOWARDS, AJAY NEHRA, MARIAN D. DAMEWOOD, JAMES W. OVERSTREET, RICHARD SADOVSKY. (2002) Best Practice Policies for Male Infertility. The Journal of Urology2138-2144
    CrossRef

  82. 82

    JONATHAN P. JAROW, IRA D. SHARLIP, ARNOLD M. BELKER, LARRY I. LIPSHULTZ, MARK SIGMAN, ANTHONY J. THOMAS, PETER N. SCHLEGEL, STUART S. HOWARDS, AJAY NEHRA, MARIAN D. DAMEWOOD, JAMES W. OVERSTREET, RICHARD SADOVSKY. (2002) Best Practice Policies for Male Infertility. The Journal of Urology 167:5, 2138-2144
    CrossRef

  83. 83

    Amy M Antman, Joseph A Politch, Elizabeth S Ginsburg. (2002) Conversion of high-response gonadotropin intrauterine insemination cycles to in vitro fertilization results in excellent ongoing pregnancy rates. Fertility and Sterility 77:4, 715-720
    CrossRef

  84. 84

    Christine L Roberts, Camille H Raynes-Greenow, Charles S Algert, Brian Peat. (2002) Higher order multiple pregnancies in New South Wales 1990-1999. The Australian and New Zealand Journal of Obstetrics and Gynaecology 42:1, 57-60
    CrossRef

  85. 85

    Babak Imani, Marinus J.C Eijkemans, Gerry H Faessen, Philippe Bouchard, Linda C Giudice, Bart C.J.M Fauser. (2002) Prediction of the individual follicle-stimulating hormone threshold for gonadotropin induction of ovulation in normogonadotropic anovulatory infertility: an approach to increase safety and efficiency. Fertility and Sterility 77:1, 83-90
    CrossRef

  86. 86

    Edward G Hughes, Mita Giacomini. (2001) Funding in vitro fertilization treatment for persistent subfertility: the pain and the politics. Fertility and Sterility 76:3, 431-442
    CrossRef

  87. 87

    Ben W.J Mol, John A Collins, Fulco Van Der Veen, Patrick M.M Bossuyt. (2001) Cost-effectiveness of hysterosalpingography, laparoscopy, and Chlamydia antibody testing in subfertile couples. Fertility and Sterility 75:3, 571-580
    CrossRef

  88. 88

    Jan-Steffen Krüssel, Barry Behr, Jens Hirchenhain, Yan Wen, Amin A Milki, Susanne Cupisti, Peter Bielfeld, Mary Lake Polan. (2000) Expression of vascular endothelial growth factor mRNA in human preimplantation embryos derived from tripronuclear zygotes. Fertility and Sterility 74:6, 1220-1226
    CrossRef

  89. 89

    BRADLEY J. VAN VOORHIS, CRAIG H. SYROP. (2000) Cost-effective Treatment for the Couple With Infertility. Clinical Obstetrics and Gynecology 43:4, 958-973
    CrossRef

  90. 90

    Nanette Elster. (2000) Less is more: the risks of multiple births. Fertility and Sterility 74:4, 617-623
    CrossRef

  91. 91

    Nicola L Dean, Simon J Phillips, William M Buckett, Marinko M Biljan, Seang Lin Tan. (2000) Impact of reducing the number of embryos transferred from three to two in women under the age of 35 who produced three or more high-quality embryos11Prize poster at the Conjoint Annual Meeting of American Society for Reproductive Medicine and Canadian Fertility and Andrology Society, Toronto, Ontario, Canada, September 25–30, 1999.. Fertility and Sterility 74:4, 820-823
    CrossRef

  92. 92

    Saed M Ziadeh. (2000) Perinatal Outcome in 41 Sets of Triplets in Jordan. Birth 27:3, 185-188
    CrossRef

  93. 93

    Gleicher, Norbert, Oleske, Denise M., Tur-Kaspa, Ilan, Vidali, Andrea, Karande, Vishvanath, . (2000) Reducing the Risk of High-Order Multiple Pregnancy after Ovarian Stimulation with Gonadotropins. New England Journal of Medicine 343:1, 2-7
    Full Text

  94. 94

    A. Rolett, J.L. Kiely. (2000) Maternal sociodemographic characteristics as risk factors for preterm birth in twins versus singletons. Paediatric and Perinatal Epidemiology 14:3, 211-218
    CrossRef

  95. 95

    Ben W.J Mol, Gouke J Bonsel, John A Collins, Maarten A.H.M Wiegerinck, Fulco van der Veen, Patrick M.M Bossuyt. (2000) Cost-effectiveness of in vitro fertilization and embryo transfer. Fertility and Sterility 73:4, 748-754
    CrossRef

  96. 96

    DC Nkemayim, ME Hammadeh, M Hippach, P Rosenbaum, W Schmidt. (2000) Complications of triple pregnancy following intracytoplasmic sperm injection: a case report. Twin Research and Human Genetics 3:2, 76-79
    CrossRef

  97. 97

    David H. Barad, Barry R. Witt. (2000) Choices: Biomedical Ethics and Women's Health: Multiple Pregnancies and Assisted Reproductive Technologies. Journal of Women's Health & Gender-Based Medicine 9:2, 101-107
    CrossRef

  98. 98

    Emmett F Branigan, M.Antoinette Estes. (2000) Minimal stimulation IVF using clomiphene citrate and oral contraceptive pill pretreatment for LH suppression. Fertility and Sterility 73:3, 587-590
    CrossRef

  99. 99

    S Skrablin. (2000) Maternal neonatal outcome in quadruplet and quintuplet versus triplet gestations. European Journal of Obstetrics & Gynecology and Reproductive Biology 88:2, 147-152
    CrossRef

  100. 100

    Angelique J Goverde, Joseph McDonnell, Jan PW Vermeiden, Roel Schats, Frans FH Rutten, Joop Schoemaker. (2000) Intrauterine insemination or in-vitro fertilisation in idiopathic subfertility and male subfertility: a randomised trial and cost-effectiveness analysis. The Lancet 355:9197, 13-18
    CrossRef

  101. 101

    Avner Hershlag. (1999) Multifetal prophylaxis—a reality?11The opinions and commentary expressed in Editor’s Corner articles are solely those of the author. Publication does not imply endorsement by the Editor or American Society for Reproductive Medicine.. Fertility and Sterility 72:6, 973-974
    CrossRef

  102. 102

    Anna Schlotzhauer, Bryan A. Liang. (1999) The ethics of selective termination cases. Journal of Legal Medicine 20:4, 441-456
    CrossRef

  103. 103

    Fergal D. Malone, David Chelmow, Achilles Athanassiou, Mary E. D'Alton. (1999) Impact of gestational age at delivery on the economics of triplet pregnancy. The Journal of Maternal-Fetal Medicine 8:6, 256-261
    CrossRef

  104. 104

    Jeffrey L. Angel, Craig S. Kalter, Walter J. Morales, Connie Rasmussen, Linda Caron. (1999) Aggressive perinatal care for high-order multiple gestations: Does good perinatal outcome justify aggressive assisted reproductive techniques?. American Journal of Obstetrics and Gynecology 181:2, 253-259
    CrossRef

  105. 105

    Bradley J Van Voorhis, Dale W Stovall, Brian D Allen, Craig H Syrop. (1998) Cost-effective treatment of the infertile couple. Fertility and Sterility 70:6, 995-1005
    CrossRef

  106. 106

    Brian P. Fitzsimmons, Michael W. Bebbington, Margo R. Fluker. (1998) Perinatal and neonatal outcomes in multiple gestations: Assisted reproduction versus spontaneous conception. American Journal of Obstetrics and Gynecology 179:5, 1162-1167
    CrossRef

  107. 107

    Steven Pierpaoli, John P. Mulhall. (1998) Vasectomy reversal in the age of intracytoplasmic sperm injection. Current Opinion in Urology 8:6, 531-534
    CrossRef

  108. 108

    Peter M. Martin, H.Gilbert Welch. (1998) Probabilities for singleton and multiple pregnancies after in vitro fertilization. Fertility and Sterility 70:3, 478-481
    CrossRef

  109. 109

    Templeton, Allan, Morris, Joan K., . (1998) Reducing the Risk of Multiple Births by Transfer of Two Embryos after in Vitro Fertilization. New England Journal of Medicine 339:9, 573-577
    Full Text

  110. 110

    Richard P. Porreco. (1998) A Guest Editorial. Obstetrical & Gynecological Survey 53:7, 393-394
    CrossRef

  111. 111

    Nancy A. Bowers. (1998) The Multiple Birth Explosion: Implications for Nursing Practice. Journal of Obstetric, Gynecologic, <html_ent glyph="@amp;" ascii="&"/> Neonatal Nursing 27:3, 302-310
    CrossRef

  112. 112

    GLADYS B. WHITE. (1998) Crisis in Assisted Conception: The British Approach to an American Dilemma. Journal of Women's Health 7:3, 321-328
    CrossRef

  113. 113

    WILLIAM E. ROBERTS, JOHN C. MORRISON. (1998) Has the Use of Home Monitors, Fetal Fibronectin, and Measurement of Cervical Length Helped Predict Labor and/or Prevent Preterm Delivery in Twins?. Clinical Obstetrics and Gynecology 41:1, 95-102
    CrossRef

  114. 114

    (1998) News, Views and Comments. Twin Research and Human Genetics 1:1, 52-56
    CrossRef

  115. 115

    Véronique Addor, Brigitte Santos-Eggimann, Claire-Lise Fawer, Fred Paccaud, André Calame. (1998) Impact of infertility treatments on the health newborns. Fertility and Sterility 69:2, 210-215
    CrossRef

  116. 116

    Richard P. Porreco, Eleanor Diss Sabin, Kent D. Heyborne, L.Gregory Lindsay. (1998) Delayed-interval delivery in multifetal pregnancy. American Journal of Obstetrics and Gynecology 178:1, 20-23
    CrossRef

  117. 117

    Christopher J. De Jonge, Don P. Wolf. (1997) Embryo number for transfer should be regulated. Fertility and Sterility 68:5, 784-786
    CrossRef

  118. 118

    Mark I. Evans, Roderick F. Hume, Shawn Polak, Yuval Yaron, Arie Drugan, Michael P. Diamond, Mark P. Johnson. (1997) The geriatric gravida: Multifetal pregnancy reduction, donor eggs, and aggressive infertility treatments. American Journal of Obstetrics and Gynecology 177:4, 875-878
    CrossRef

  119. 119

    Keith Alan Byers. (1997) Infertility and in vitro fertilization. Journal of Legal Medicine 18:3, 265-313
    CrossRef

  120. 120

    Peter N. Kolettis, Anthony J. Thomas. (1997) Vasoepididymostomy for Vasectomy Reversal: A Critical Assessment in the Era of Intracytoplasmic Sperm Injection. The Journal of Urology 158:2, 467-470
    CrossRef

  121. 121

    Peter N. Kolettis, Anthony J. Thomas. (1997) Vasoepididymostomy for Vasectomy Reversal. The Journal of Urology467-470
    CrossRef

  122. 122

    ARNOLD COHEN. (1997) Managed Health Care's Approach to Infertility. Clinical Obstetrics and Gynecology 40:2, 420-426
    CrossRef

  123. 123

    R. C Martin-Du Pan, A. Campana. (1997) Etiologie de 350 cas de stérilité masculine. Effet de divers traitements sur la qualité du sperme et analyse de leur rôle dans la survenue de 100 grossesses. Andrologie 7:2, 199-211
    CrossRef

  124. 124

    Jan Roest, Arne M. van Heusden, Arie Verhoeff, Harold V.H. Mous, Gerard H. Zeilmaker. (1997) A triplet pregnancy after in vitro fertilization is a procedure-related complication that should be prevented by replacement of two embryos only. Fertility and Sterility 67:2, 290-295
    CrossRef

  125. 125

    James M. Goldfarb, Barry Peskin, Cynthia Austin, Hanna Lisbona. (1997) Evaluation of predictive factors for multiple pregnancies during gonadotropin/IUI treatment. Journal of Assisted Reproduction and Genetics 14:2, 88-91
    CrossRef

  126. 126

    Peter N. Schlegel. (1997) Is assisted reproduction the optimal treatment for varicocele-associated male infertility? a cost-effectiveness analysis. Urology 49:1, 83-90
    CrossRef

  127. 127

    Christian P. Pavlovich, Peter N. Schlegel. (1997) Fertility options after vasectomy: A cost-effectiveness analysis. Fertility and Sterility 67:1, 133-141
    CrossRef

  128. 128

    Robert H. Blank. (1996) The medical marketplace and the diffusion of technologies. Health Care Analysis 4:4, 321-324
    CrossRef

  129. 129

    Allan Templeton, Joan K Morris, William Parslow. (1996) Factors that affect outcome of in-vitro fertilisation treatment. The Lancet 348:9039, 1402-1406
    CrossRef

  130. 130

    Michelle Smith-Levitin, Ania Kowalik, Jason Birnholz, Daniel W. Skupski, J. Milton Hutson, Frank A. Chervenak, Zev Rosenwaks. (1996) Selective reduction of multifetal pregnancies to twins improves outcome over nonreduced triplet gestations. American Journal of Obstetrics and Gynecology 175:4, 878-882
    CrossRef

  131. 131

    ALAN B. COPPERMAN, TANMOY MUKHERJEE, JENNIFER SHAER, DIPTI PATEL, BENJAMIN SANDLER, LAWRENCE GRUNFELD, MARIA BUSTILLO. (1996) A Cost Analysis of In Vitro Fertilization Versus Tubal Surgery Within an Institution Under Two Payment Systems. Journal of Women's Health 5:4, 335-341
    CrossRef

  132. 132

    Alan S. Penzias, Alan H. DeCherney. (1996) Is there ever a role for tubal surgery?. American Journal of Obstetrics and Gynecology 174:4, 1218-1223
    CrossRef

  133. 133

    Richard Depp, George A. Macones, Marc F. Rosenn, Elene Turzo, Ronald J. Wapner, Vivian J. Weinblatt. (1996) Multifetal pregnancy reduction: Evaluation of fetal growth in the remaining twins. American Journal of Obstetrics and Gynecology 174:4, 1233-1240
    CrossRef

  134. 134

    Jacques Salat-Baroux, Jean Marie Antoine. (1996) Multiple pregnancies: the price to pay. European Journal of Obstetrics & Gynecology and Reproductive Biology 65, S17-S18
    CrossRef

  135. 135

    Marc J. N. C. Keirse, Frans M. Helmerhorst. (1995) The impact of assisted reproduction on perinatal health care. Sozial- und Prventivmedizin SPM 40:6, 343-351
    CrossRef

  136. 136

    MACHELLE M. SEIBEL, JUDITH BERNSTEIN. (1994) Perspective: Cost-Effective Trial Balloons and the Potential for Bias: The Case Against in Vitro Fertilization. Journal of Women's Health 3:6, 411-414
    CrossRef

  137. 137

    Collins, John A., . (1994) Reproductive Technology -- The Price of Progress. New England Journal of Medicine 331:4, 270-271
    Full Text